Related Experiment Videos
Expanded polytetrafluoroethylene augmentation of the lower face
1Department of Otorhinolaryngology, Mayo Clinic, Rochester, MN 55905, USA.
The Laryngoscope
|May 1, 1996
Summary
Expanded polytetrafluoroethylene (E-PTFE) patches offer a new option for lower facial rejuvenation. This study found E-PTFE soft-tissue patches had a low complication rate in 41 patients over 2.5 to 4.5 years.
Area of Science:
- Plastic Surgery
- Dermatology
- Biomaterials Science
Background:
- Facial rejuvenation commonly utilizes soft-tissue fillers, each with inherent risks and benefits.
- The U.S. Food and Drug Administration has approved expanded polytetrafluoroethylene (E-PTFE) for facial soft-tissue augmentation.
Purpose of the Study:
- To evaluate the technical aspects and long-term efficacy of E-PTFE soft-tissue patches for lower facial augmentation.
- To compare E-PTFE with other available facial rejuvenation techniques.
Main Methods:
- A retrospective study involving 41 patients who received E-PTFE soft-tissue patches for lower facial augmentation between January 1991 and December 1993.
- 115 implant sites were analyzed with a postsurgical follow-up ranging from 2.5 to 4.5 years.
Main Results:
- Complications occurred in 4 patients: one implant removal due to seroma, secondary augmentation for 4 implants in 2 patients, and one revision for malposition.
- No cases of implant infection, extrusion, long-term inflammation, or capsule formation were reported.
Conclusions:
- E-PTFE soft-tissue patches demonstrate a favorable safety profile for lower facial augmentation with a low incidence of significant complications.
- The technique presents a viable alternative for facial rejuvenation, warranting further investigation into its long-term efficacy compared to existing methods.